• user warning: Got error 28 from storage engine query: SELECT t.tid, t.* FROM term_data t INNER JOIN term_hierarchy h ON h.parent = t.tid WHERE h.tid = 5394 ORDER BY weight, name in /var/www/www.fnno.com/htdocs/modules/taxonomy/taxonomy.module on line 755.
  • user warning: Got error 28 from storage engine query: SELECT t.* FROM term_node r INNER JOIN term_data t ON r.tid = t.tid INNER JOIN vocabulary v ON t.vid = v.vid WHERE r.vid = 36290 ORDER BY v.weight, t.weight, t.name in /var/www/www.fnno.com/htdocs/modules/taxonomy/taxonomy.module on line 617.
  • user warning: Got error 28 from storage engine query: SELECT t.* FROM term_node r INNER JOIN term_data t ON r.tid = t.tid INNER JOIN vocabulary v ON t.vid = v.vid WHERE r.vid = 29247 ORDER BY v.weight, t.weight, t.name in /var/www/www.fnno.com/htdocs/modules/taxonomy/taxonomy.module on line 617.
  • user warning: Got error 28 from storage engine query: SELECT t.* FROM term_node r INNER JOIN term_data t ON r.tid = t.tid INNER JOIN vocabulary v ON t.vid = v.vid WHERE r.vid = 28735 ORDER BY v.weight, t.weight, t.name in /var/www/www.fnno.com/htdocs/modules/taxonomy/taxonomy.module on line 617.
  • user warning: Got error 28 from storage engine query: SELECT t.* FROM term_node r INNER JOIN term_data t ON r.tid = t.tid INNER JOIN vocabulary v ON t.vid = v.vid WHERE r.vid = 28727 ORDER BY v.weight, t.weight, t.name in /var/www/www.fnno.com/htdocs/modules/taxonomy/taxonomy.module on line 617.
  • user warning: Got error 28 from storage engine query: SELECT t.* FROM term_node r INNER JOIN term_data t ON r.tid = t.tid INNER JOIN vocabulary v ON t.vid = v.vid WHERE r.vid = 27604 ORDER BY v.weight, t.weight, t.name in /var/www/www.fnno.com/htdocs/modules/taxonomy/taxonomy.module on line 617.
  • user warning: Got error 28 from storage engine query: SELECT t.* FROM term_node r INNER JOIN term_data t ON r.tid = t.tid INNER JOIN vocabulary v ON t.vid = v.vid WHERE r.vid = 27567 ORDER BY v.weight, t.weight, t.name in /var/www/www.fnno.com/htdocs/modules/taxonomy/taxonomy.module on line 617.
  • user warning: Got error 28 from storage engine query: SELECT t.* FROM term_node r INNER JOIN term_data t ON r.tid = t.tid INNER JOIN vocabulary v ON t.vid = v.vid WHERE r.vid = 27367 ORDER BY v.weight, t.weight, t.name in /var/www/www.fnno.com/htdocs/modules/taxonomy/taxonomy.module on line 617.
  • user warning: Got error 28 from storage engine query: SELECT t.* FROM term_node r INNER JOIN term_data t ON r.tid = t.tid INNER JOIN vocabulary v ON t.vid = v.vid WHERE r.vid = 27366 ORDER BY v.weight, t.weight, t.name in /var/www/www.fnno.com/htdocs/modules/taxonomy/taxonomy.module on line 617.
  • user warning: Got error 28 from storage engine query: SELECT t.* FROM term_node r INNER JOIN term_data t ON r.tid = t.tid INNER JOIN vocabulary v ON t.vid = v.vid WHERE r.vid = 27365 ORDER BY v.weight, t.weight, t.name in /var/www/www.fnno.com/htdocs/modules/taxonomy/taxonomy.module on line 617.
  • user warning: Got error 28 from storage engine query: SELECT t.* FROM term_node r INNER JOIN term_data t ON r.tid = t.tid INNER JOIN vocabulary v ON t.vid = v.vid WHERE r.vid = 27358 ORDER BY v.weight, t.weight, t.name in /var/www/www.fnno.com/htdocs/modules/taxonomy/taxonomy.module on line 617.

ceph

Teva Pharmaceuticals Announced It Will Acquire Cephalon For $6.8 Billion

Published on Mon, 05/02/2011 - 10:28
By FNNO Staff

The transaction is expected to be completed in Q3 of 2011.

Shlomo Yanai, President and Chief Executive Officer of Teva said, "We are embarking today on a new and exciting future for Teva's branded business, and we are delighted that we will be working together with the Cephalon team.

acquisition, analysis, ceph, cephalon, finance, investing, merger, news, stock, teva, teva pharmaceuticals, trading

Teva Pharmaceuticals (NASDAQ:TEVA) and Cephalon (NASDAQ:CEPH) announced that their boards of directors unanimously approved a definitive agreement under which Teva will acquire all of the outstanding shares of Cephalon for $81.50

By FNNO Staff
fnnonline@gmail.com

Morning Market Snapshot: April 8, 2011

Published on Fri, 04/08/2011 - 07:15
By FNNO Staff
analysis, ba, boeing, business, ceph, cephalon, expe, expedia, financial, hon, honeywell, market, news, rio, rio tinto, riversdale mining, stock, trading, valeant pharmaceuticals, vrx

Good Morning. It's Friday, April 8, 2011. At this hour, U.S. equity futures are higher. Overseas, the Asian markets advanced, while the European markets are up. Rio Tinto (RIO) said it acquired a majority interest in Riversdale

By FNNO Staff
fnnonline@gmail.com

Cephalon rejects Valeant Pharmaceuticals takeover bid

Published on Wed, 04/06/2011 - 08:02
By FNNO Staff
acquisition, bid, buyout, ceph, cephalon, health, m&a, merger, offer, pharma, purchase, reject, share, stock, trade, valeant

Cephalon (CEPH) announced its board formally rejected Valeant Pharmaceuticals International, Inc.'s March 29 unsolicited proposal to purchase the company for $73 per share. Shares of Cephalon are down over 1% to $76.50 in pre-mark

By FNNO Staff
fnnonline@gmail.com

Morning Market Snapshot: April 6, 2011

Published on Wed, 04/06/2011 - 07:26
By FNNO Staff
analysis, bloaq, blockbuster, business, ceph, cephalon, dish, dish network, financial, lgf, lionsgate, mad men, market, nasdaq omx, ndaq, netflix, news, nflx, nyse euronext, nyx, rio, rio tinto, stock, tm, toyota motor, trading, valeant, vrx

Good Morning. It's Wednesday, April 6, 2011. At this hour, U.S. equity futures are up. Overseas, the Asian markets were mixed, while the European markets are higher.

By FNNO Staff
fnnonline@gmail.com

UBS Downgrades Cephalon, Raises Target Price

Published on Thu, 03/31/2011 - 09:45
By FNNO Staff

The bank sees some upside to the $73 offer, but not much. Valeant could increase its offer marginally, and there is a reasonable possibility of an additional suitor coming along with a higher bid.

Shares of Cephalon are trading down 0.19% at $75.30.

acquisition, analyst, bank, bid, buyout, ceph, cephalon, m&a, merger, nasdaq, pharma, price, share, stock, trade, ubs, valeant

UBS downgraded Cephalon (NASDAQ:CEPH) to neutral from buy, while raising its target price to $78, after a $73 per share buyout offer from Valeant was made public.

By FNNO Staff
fnnonline@gmail.com

What's In The News: March 31, 2011

Published on Thu, 03/31/2011 - 07:27
By FNNO Staff
analysis, berkshire hathaway, BRK, business, ceph, cephalon, chrysler, david sokol, financial, gasoline, insider trading, ipo, lubrizol, market, news, prius, stock, toyota, trading, valeant pharmaceutical, vrx, warren buffett

This is what's in the news for Thursday, March 31st. the Wall Street Journal reports that Berkshire Hathaway's (BRK.A) David Sokol has resigned over his personal stock trading...

By FNNO Staff
fnnonline@gmail.com

Upgrades and Downgrades: March 30, 2011

Published on Wed, 03/30/2011 - 08:52
By FNNO Staff

JMP Securities also downgraded Cephalon (CEPH) to Market Perform from Outperform. The firm cited the acquisition proposal by Valeant (VRX), which the firm views as attractive and thinks shareholders will ultimately accept an offer

Meanwhile, Citigroup downgraded Gannett (GCI) to Hold from Buy.

analysis, business, ceph, cephalon, financial, gannett, gci, kft, kraft, market, news, peet, peet's coffee, rural/metro, rurl, sbux, starbucks, stock, tibco, tibx, trading

JMP Securities has reportedly downgraded Rural/Metro (RURL) to Market Perform from Outperform. The firm cited the company's acquisition by Warburg Pincus as its reason. Shares closed at $17.04.

By FNNO Staff
fnnonline@gmail.com

Pre-Market Movers: March 30th, 2011

Published on Wed, 03/30/2011 - 08:42
By FNNO Staff
analysis, bhp, business, ceph, cephalon, financial, market, news, pre-market movers, stock, trading, valeant pharmaceuticals, vrx

Equity futures are pointing higher this morning with the Dow Jones Industrial Average looking to open 44 points higher while the broader S&P500 is looking to open 6 points higher. Moving fast in the pre-market session are shar

By FNNO Staff
fnnonline@gmail.com

Cephalon up 31% in Pre-Market Trade on Reaction to Buyout News

Published on Wed, 03/30/2011 - 08:05
By FNNO Staff

The stock surged in after-hours trading Tuesday after Valeant Pharmaceuticals (VRX) said it made a proposal to the Board of Directors to acquire Cephalon for $73.00 per share in cash. The proposal, valued at approximately $5.7 bil

Shares of Valenant are up some 18% to $52.50 in pre-market action.

acquisition, analysis, business, ceph, cephalon, financial, market, merger, news, stock, trading, valeant pharmaceuticals, vrx

Cephalon (CEPH) is up 31% in pre-market trade, continuing the climb started last night on news of an acquisition offer. Shares are currently trading at $77.24

By FNNO Staff
fnnonline@gmail.com

Morning Market Snapshot: March 30, 2011

Published on Wed, 03/30/2011 - 07:20
By FNNO Staff
analysis, business, ceph, cephalon, dean foods, df, financial, market, news, stock, texas instruments, tot, total, trading, txn, valeant pharmaceuticals, vrx

Good Morning. It's Wednesday, March 30, 2011. At this hour, U.S. equity futures are higher. Overseas, the Asian markets advanced, while the European markets are up.

By FNNO Staff
fnnonline@gmail.com

Most Popular Video News